These results suggest that elevated expression of MCP-4 in ovarian cancer tissues is associated with poor prognosis and that high expression of MCP-4 may serve as an independent risk factor for predicting the prognosis of patients with ovarian cancer. Here, CCL13 is linked to ovarian cancer.